Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial.

Stiell IG, Hébert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, Dreyer JF, Clement C, Battram E, Watpool I, Mason S, Klassen T, Weitzman BN.

Lancet. 2001 Jul 14;358(9276):105-9.

PMID:
11463411
2.

New strategies for clinical trials in patients with sepsis and septic shock.

Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S; UK Medical Research Council International Working Party.

Crit Care Med. 2001 Apr;29(4):880-6. Review.

PMID:
11373487
3.

Randomized controlled comparison of epidural bupivacaine versus pethidine for analgesia in labour.

Loughnan BA, Carli F, Romney M, Doré CJ, Gordon H.

Br J Anaesth. 2000 Jun;84(6):715-9.

4.

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG.

JAMA. 2000 Feb 23;283(8):1016-24.

PMID:
10697061
5.
6.

More powerful randomization-based p-values in double-blind trials with non-compliance.

Rubin DB.

Stat Med. 1998 Feb 15;17(3):371-85; discussion 387-9.

PMID:
9493260
7.

The hope and the hazards of using compliance data in randomized controlled trials.

Pocock SJ, Abdalla M.

Stat Med. 1998 Feb 15;17(3):303-17.

PMID:
9493256
8.

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al.

JAMA. 1994 Jun 15;271(23):1836-43.

PMID:
8196140
9.

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.

Houbiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, et al.

Lancet. 1994 Aug 27;344(8922):573-8.

PMID:
7914960
10.

Explanatory and pragmatic attitudes in therapeutical trials.

Schwartz D, Lellouch J.

J Chronic Dis. 1967 Aug;20(8):637-48. No abstract available.

PMID:
4860352
11.

On estimating efficacy from clinical trials.

Sommer A, Zeger SL.

Stat Med. 1991 Jan;10(1):45-52. Erratum in: Stat Med 1994 Sep 30;13(18):1897.

PMID:
2006355
12.

Analysis of clinical trials by treatment actually received: is it really an option?

Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB.

Stat Med. 1991 Oct;10(10):1595-605.

PMID:
1947515
13.

Intention-to-treat analysis: implications for quantitative and qualitative research.

Newell DJ.

Int J Epidemiol. 1992 Oct;21(5):837-41. Review.

PMID:
1468842
14.
15.

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG.

Br J Cancer. 1976 Dec;34(6):585-612.

16.

The qualification and disqualification of patients and events in long-term cardiovascular clinical trials.

Gent M, Sackett DL.

Thromb Haemost. 1979 Feb 28;41(1):123-34. Review. No abstract available.

PMID:
384581
Items per page

Supplemental Content

Write to the Help Desk